FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer-Reference-Cited by-同舟云学术

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer

Published:2016-08-13 Issue:4 Volume:2 Page:223-233
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Theelen Willemijn SME¹,Mittempergher Lorenza²,Willems Stefan M³,Bosma Astrid J²,Peters Dennis DGC⁴,van der Noort Vincent⁵,Japenga Eva J⁶,Peeters Ton³,Koole Koos³,Šuštić Tonći²,Blaauwgeers JL⁷,van Noesel Carel J⁸,Bernards René²,van den Heuvel Michel M¹

Affiliation:

1. Department of Thoracic Oncology; The Netherlands Cancer Institute; Amsterdam The Netherlands

2. Division of Molecular Carcinogenesis; The Netherlands Cancer Institute; Amsterdam The Netherlands

3. Department of Pathology; University Medical Center Utrecht; Utrecht The Netherlands

4. Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology; The Netherlands Cancer Institute; Amsterdam The Netherlands

5. Department of Biometrics; The Netherlands Cancer Institute; The Netherlands

6. Department of Pulmonology; OLVG; Amsterdam The Netherlands

7. Department of Pathology; OLVG; Amsterdam The Netherlands

8. Department of Pathology; Academic Medical Center; Amsterdam The Netherlands

Funder

European Union FP7 grant ‘Eurocanplatform’

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference52 articles.

1. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients;Kelsey;Cancer,2009

2. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis;Lee;J Natl Cancer Inst,2013

3. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

4. The FGF family: biology, pathophysiology and therapy;Beenken;Nat Rev Drug Discov,2009

5. Fibroblast growth factor signalling: from development to cancer;Turner;Nat Rev Cancer,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory mechanism of the Glabrene against non‐small cell lung cancer by suppressing FGFR3;Environmental Toxicology;2024-03-22

2. RT-PCR assay to detect FGFR3::TACC3 fusions in formalin-fixed, paraffin-embedded glioblastoma samples;Neuro-Oncology Practice;2024-01-05

3. FGFR3 and FGFR4 overexpression in juvenile nasopharyngeal angiofibroma: impact of smoking history and implications for personalized management;Journal of Applied Genetics;2023-09-01

4. Sanggenol B, a plant bioactive, as a safer alternative to tackle cancer by antagonising human FGFR;Journal of Biomolecular Structure and Dynamics;2023-08-08

5. Occupational exposure to diesel engine exhaust and serum levels of microRNAs in a cross‐sectional molecular epidemiology study in China;Environmental and Molecular Mutagenesis;2023-03